Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

GSTC

Globestar Therapeutics (PK) (GSTC)

Globestar Therapeutics Corporation (PK)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:GSTC
일자시간출처헤드라인심볼기업
2024/02/1601:33Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
2024/01/2007:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2024/01/0306:21Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/11/1402:32Edgar (US Regulatory)Form 8-K - Current reportUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/08/1805:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/08/1505:31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/06/2806:12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/05/3119:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/05/1605:16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/05/0402:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/05/0402:30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/04/0705:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/02/1407:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2023/01/1003:48Edgar (US Regulatory)Annual Report (10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2022/12/3006:37Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2022/08/2306:31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2022/08/1605:29Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2022/05/1705:55Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2021/10/1221:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2021/10/0421:49Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2021/09/2021:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1707:30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1707:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1707:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1500:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1500:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1500:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/1423:44Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/0906:37Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
2018/11/0806:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
 검색 관련기사 보기:USOTC:GSTC